Genetic tests to identify heritable mutations that increase the risk of developing colorectal and endometrial cancer are now available on Medicare subsidy. The new MBS items that take effect from 1 May, will make genetic testing available for the identification of heritable mutations associated with the clinical presentations of Lynch Syndrome (LS), Familial Adenomatous Polyposis ...
MBS items for genetic tests for heritable mutations relating to colorectal and endometrial cancer
By Michael Woodhead
26 May 2020